Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply

Detalles Bibliográficos
Autores principales: Gao, Zhen, Huang, Shujie, Wang, Sichao, Tang, Dezhao, Xu, Wei, Zeng, Ruijie, Qiao, Guibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585616/
https://www.ncbi.nlm.nih.gov/pubmed/37868211
http://dx.doi.org/10.1016/j.lanwpc.2023.100927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585616/
https://www.ncbi.nlm.nih.gov/pubmed/37868211
http://dx.doi.org/10.1016/j.lanwpc.2023.100927

Ejemplares similares